ancile


Also found in: Wikipedia.

ancile

(ænˈsaɪliː; Latin ænˈkiːleɪ)
n
a shield that was said to have fallen from heaven, on whose preservation the fortune of Rome was thought to depend
References in periodicals archive ?
In his last appointment, Dunlap was responsible for Global Sales and Alliances at ANCILE Solutions, Inc.
David Lingg is VP of technology integration with ANCILE Solutions, Inc.
The joint Sidra Ancile Global Structured Trade Finance Fund (STFIF), which was regulated under both the CMA and the Commission de Surveillance du Secteur Financier (CSSF) of Luxembourg closed its first offering of subscription in September and have since approved investments in various transactions for its current assets under management.
Now the sold business will operate under the name of ANCILE Solutions Inc, which will continue working with RWD and support its software activities.
Ancile Pharmaceuticals, Roche, Novartis, Organon USA Inc.
Similarly, for those organizations that purchased the RWD, InfoPak or uPerform solutions to support their Oracle deployments and now have questions following the spin out of those products from RWD to the new Ancile organization, we wanted to offer what we believe is a superior solution as an alternative.
Sidra Capital (Sidra), a Saudi Arabia Capital Market Authority (CMA)-regulated Shariah-compliant financial services company and INOKS Capital SA (INOKS), an alternative investment house specialised in commodities financing in emerging markets and regulated by the Swiss Financial Market Supervisory Authority (FINMA), recently announced investments in various transactions by its jointly managed Sidra Ancile Global Structured Trade Finance Fund (STFIF) totaling $13.
Puig, VP for the Private Sector and Non-Sovereign Guaranteed Operations, IDB; Ancile Brewster, IDB Country Manager, Arthur Lok Jack, Chairman, Associated Brands Investments Ltd.
Clients included Tesla Motors, ANCILE Solutions, Ubicom, Roadnet Technologies and Duke University.
Previously, Costas served as a key member of a number of executive management teams in biotechnology companies, including Trega Biosciences, PharmaPrint, and Ancile Pharmaceuticals, where he established and led a number of research, preclinical, development, clinical, and regulatory groups and was fully engaged in strategic planning, operations and product positioning.
OTCBB:AQSE) today announced a Letter of Intent with Ancile Pharmaceuticals, Inc.